๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia

โœ Scribed by Whitlock, J A; Wells, R J; Hord, J D; Janco, R L; Greer, J P; Gay, J C; Edwards, J R; McCurley, T L; Lukens, J N

Book ID
110053430
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
70 KB
Volume
11
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Mitoxantrone and high-dose cytosine arab
Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia
โœ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 447 KB ๐Ÿ‘ 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete

acute tumor lysis syndrome and treatment
acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide
โœ Robert D. McCroskey; Deane F. Mosher; Cory D. Spencer; Edward Prendergast; Walte ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 501 KB

Acute tumor lysis syndrome resulting from rapid neoplastic cell lysis after chemotherapy is an unusual event, generally seen in histologically aggressive lymphatic tumors. The authors saw four patients who developed acute tumor lysis syndrome when treated for advanced-stage, refractory chronic lymph